Skip to main content
. Author manuscript; available in PMC: 2024 May 1.
Published in final edited form as: J Allergy Clin Immunol Pract. 2023 Feb 3;11(5):1485–1493.e8. doi: 10.1016/j.jaip.2023.01.037

Table 1.

Features of the participants. Data represent the mean ± standard deviation or the number of participants (%).

Feature Participants (N=1,074)
Age (months) 32.7 ± 14.7
Age of symptom onset (months) 12.9 ± 10.6
Male 681 (63.4)
Self-reported race
 White 733 (68.2)
 Black 235 (21.9)
 Asian 22 (2.0)
 More than one race 60 (5.6)
 Reported as “other” 24 (2.2)
Hispanic ethnicity 283 (26.4)
Family medical history
 Mother with asthma 352 (32.8)
 Mother with allergies 280 (26.1)
 Father with asthma 397 (37.0)
 Father with allergies 308 (28.7)
Household exposures
 Tobacco smoke 293 (27.3)
 Cat 169 (15.7)
 Dog 325 (30.3)
Self-reported triggers
 Inhaled allergens 566 (52.7)
 Exercise 524 (48.8)
 Respiratory infections 1,027 (95.6)
 Chemicals/irritants 219 (20.4)
 Weather changes 765 (71.2)
 Cold air 549 (51.1)
 Emotions 328 (30.5)
 Tobacco 265 (24.7)
 Food 51 (4.7)
Ever had eczema 513 (47.8)
Medication use in past year (at any time)
 Inhaled corticosteroid 459 (42.7)
 Leukotriene receptor antagonist 113 (10.5)
Exacerbation history (past year)
 Any oral corticosteroid burst 684 (63.7)
  Number of oral corticosteroid bursts 1.3 ± 1.3
 Any unscheduled visit 1,037 (96.6)
  Number of unscheduled visits 3.5 ± 3.3
 Any Emergency Department visit 801 (74.6)
  Number of Emergency Department visits 2.1 ± 2.0
 Any hospitalization 126 (11.7)